Tonix Pharmaceuticals
Presence
Tonix Pharmaceuticals is a company listed under the stock ticker TNXP (US).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Tonix Pharmaceuticals
- Seth Lederman, Co-Founder, Chairman and Chief Executive Officer
- Carolyn Taylor, Director
- Adeoye Olukotun, Director
Create your alert
to follow the executive moves at Tonix Pharmaceuticals.
Pharmaceuticals
Tonix Pharmaceuticals has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Tonix Pharmaceuticals
- Press Releases
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
- Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024
- Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
- Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
- Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
- Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
- Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia
- Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
- Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference
- View more press releases Close
Social media about Tonix Pharmaceuticals
- Tonix Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Tonix Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Seth Lederman 
Call Tonix Pharmaceuticals at +1 212...
